Detalles de la búsqueda
1.
Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid population.
Manag Care
; 21(1): 49-58, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22332457
2.
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
Ann Pharmacother
; 45(4): 441-51, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21415162
3.
Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
Depress Anxiety
; 27(1): 78-89, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-19569060
4.
Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population.
Value Health
; 12(5): 708-15, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19508658
5.
Determinants of direct cost differences among US employees with major depressive disorders using antidepressants.
Pharmacoeconomics
; 27(6): 507-17, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19640013
6.
Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs.
J Med Econ
; 12(2): 124-35, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19566483
7.
Antidepressant treatment patterns and costs among US employees.
J Med Econ
; 12(1): 36-45, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19450063
8.
Annual costs associated with diagnosis of uterine leiomyomata.
Obstet Gynecol
; 108(4): 930-7, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17012456
9.
The economic consequences of irritable bowel syndrome: a US employer perspective.
Arch Intern Med
; 163(8): 929-35, 2003 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-12719202
10.
Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anaemia : a meta-analysis.
Clin Drug Investig
; 25(1): 33-48, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-17523745
11.
Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.
CNS Drugs
; 26(7): 581-600, 2012 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22712698
12.
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs.
J Med Econ
; 14(4): 508-15, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21692605
13.
Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy change.
J Clin Psychiatry
; 72(6): 787-94, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21294993
14.
Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram.
Am Health Drug Benefits
; 4(2): 78-87, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25126340
15.
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
Curr Med Res Opin
; 27(6): 1089-96, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21438794
16.
Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons.
J Med Econ
; 13(2): 314-23, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20504111
17.
Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.
J Med Econ
; 13(4): 599-609, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20879834
18.
Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United States.
J Occup Environ Med
; 52(2): 115-24, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20134337
19.
Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population.
Curr Med Res Opin
; 25(3): 755-64, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19199435
20.
Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants.
Curr Med Res Opin
; 24(10): 2805-13, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18755054